These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38630433)

  • 1. Challenges recruiting and retaining people at risk for HIV who use methamphetamine in a randomized PrEP adherence trial in Seattle, WA.
    McMahan VM; Atkins DL; Buckler S; Violette LR; Niemann L; Frank N; Kimiam Waters ; Herrera Perales LE; Viquez L; Tung E; Stekler JD
    Int J STD AIDS; 2024 Apr; ():9564624241244835. PubMed ID: 38630433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol Development for HMU! (HIV Prevention for Methamphetamine Users), a Study of Peer Navigation and Text Messaging to Promote Pre-Exposure Prophylaxis Adherence and Persistence Among People Who Use Methamphetamine: Qualitative Focus Group and Interview Study.
    McMahan VM; Frank N; Buckler S; Violette LR; Baeten JM; Banta-Green CJ; Barnabas RV; Simoni J; Stekler JD
    JMIR Form Res; 2020 Sep; 4(9):e18118. PubMed ID: 32924952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial.
    Swendeman D; Rotheram-Borus MJ; Arnold EM; Fernández MI; Comulada WS; Lee SJ; Ocasio MA; Ishimoto K; Gertsch W; Duan N; Reback CJ; Murphy DA; Lewis KA;
    Lancet Digit Health; 2024 Mar; 6(3):e187-e200. PubMed ID: 38395539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    Celum C; Hosek S; Tsholwana M; Kassim S; Mukaka S; Dye BJ; Pathak S; Mgodi N; Bekker LG; Donnell DJ; Wilson E; Yuha K; Anderson PL; Agyei Y; Noble H; Rose SM; Baeten JM; Fogel JM; Adeyeye A; Wiesner L; Rooney J; Delany-Moretlwe S
    PLoS Med; 2021 Jun; 18(6):e1003670. PubMed ID: 34143779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure Prophylaxis Awareness and Use Among Cisgender Men Who Have Sex With Men and Use Methamphetamine in 3 Western US Cities.
    McMahan VM; Moreno C; Al-Tayyib A; Menza TW; Orellana ER; Bhattarai A; Stekler JD; Glick SN
    Sex Transm Dis; 2020 Apr; 47(4):217-223. PubMed ID: 31923138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Text Messaging-Based Support Intervention to Enhance Pre-exposure Prophylaxis for HIV Prevention Adherence During Pregnancy and Breastfeeding: Protocol for a Randomized Controlled Trial.
    Mogaka JN; Otieno FA; Akim E; Beima-Sofie K; Dettinger J; Gomez L; Marwa M; Odhiambo B; Ngure K; Ronen K; Sharma M; John-Stewart G; Richardson B; Stern J; Unger J; Udren J; Watoyi S; Pintye J; Kinuthia J
    JMIR Res Protoc; 2023 Jan; 12():e41170. PubMed ID: 36716092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project.
    Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B;
    J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.
    Grant RM; Anderson PL; McMahan V; Liu A; Amico KR; Mehrotra M; Hosek S; Mosquera C; Casapia M; Montoya O; Buchbinder S; Veloso VG; Mayer K; Chariyalertsak S; Bekker LG; Kallas EG; Schechter M; Guanira J; Bushman L; Burns DN; Rooney JF; Glidden DV;
    Lancet Infect Dis; 2014 Sep; 14(9):820-9. PubMed ID: 25065857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial.
    Kawichai S; Songtaweesin WN; Wongharn P; Phanuphak N; Cressey TR; Moonwong J; Vasinonta A; Saisaengjan C; Chinbunchorn T; Puthanakit T
    JMIR Mhealth Uhealth; 2022 Apr; 10(4):e25561. PubMed ID: 35451976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a targeted educational intervention to increase pre-exposure prophylaxis uptake among cisgender men and transgender individuals who have sex with men and use methamphetamine in Seattle (WA, USA).
    McMahan VM; Martin A; Garske L; Violette LR; Andrasik MP; Baeten JM; Banta-Green C; Stekler JD
    Sex Health; 2019 Apr; 16(2):139-147. PubMed ID: 30739638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study).
    Groot Bruinderink ML; Boyd A; Coyer L; Boers S; Blitz L; Brand JM; Götz HM; Stip M; Woudstra J; Yap K; Vermey K; Matser A; Feddes AR; Jongen VW; Prins M; Hoornenborg E; van Harreveld F; Schim van der Loeff MF; Davidovich U
    JMIR Res Protoc; 2023 Nov; 12():e51023. PubMed ID: 37938875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants.
    O'Halloran C; Rice B; White E; Desai M; Dunn DT; McCormack S; Sullivan AK; White D; McOwan A; Gafos M
    Int J Drug Policy; 2019 Dec; 74():246-254. PubMed ID: 31739177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B;
    AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
    Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
    J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapting Effective mHealth Interventions to Improve Uptake and Adherence to HIV Pre-Exposure Prophylaxis Among Thai Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial.
    Wang B; Janamnuaysook R; MacDonell K; Rongkavilit C; Schieber E; Naar S; Phanuphak N
    JMIR Res Protoc; 2023 Sep; 12():e46435. PubMed ID: 37665622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    Sevelius JM; Glidden DV; Deutsch M; Welborn L; Contreras A; Salinas A; Venegas L; Grant RM
    J Acquir Immune Defic Syndr; 2021 Dec; 88(S1):S27-S38. PubMed ID: 34757990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-behavioral correlates of pre-exposure prophylaxis use and correct adherence in men who have sex with men in West Africa.
    Eubanks A; Coulibaly B; Dembélé Keita B; Anoma C; Dah TTE; Mensah E; Kaba S; Lokrou KJ; Ouedraogo FR; Badjassim AMF; Maradan G; Bourrelly M; Mora M; Riegel L; Rojas Castro D; Yaya I; Spire B; Laurent C; Sagaon-Teyssier L;
    BMC Public Health; 2022 Sep; 22(1):1832. PubMed ID: 36175860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.